Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Mechanisms of action of anti-Aβ-antibodies. Anti-Aβ-antibodies can... | Download Scientific Diagram
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
Frontiers | Alzheimer's disease: a mini-review for the clinician
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
